Cancer Cell
Top Tier Verified Publisher
About Cancer Cell
Cancer Cell is a prominent academic journal specializing in various scientific research fields. Published by Elsevier in NL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 1535-6108. With a current Impact Factor of 64.500, Cancer Cell maintains rigorous standards of Peer Review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Editorial Perspective & Metric Analysis
Based on current metadata, Cancer Cell maintains a high-tier position in the NL academic market. With an impact factor of 64.50, it remains a highly cited venue for researchers in its specific sub-fields.
Submission Tips for Cancer Cell
- The average time from submission to first decision is 51 days, which is moderate for the field.
| ISSN (Print) | 1535-6108 |
|---|---|
| ISSN (Online) | 1878-3686 |
| Publisher | Elsevier |
| Country | Netherlands |
| APC / Cost | Inquire with Publisher |
About Cancer Cell
Cancer Cell is a prominent academic journal specializing in various scientific research fields. Published by Elsevier in NL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 1535-6108. With a current impact factor of 64.500, Cancer Cell maintains rigorous standards of peer review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Links
Frequently Asked Questions about Cancer Cell
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Impact Factor
Historical Trend
The impact factor has remained stable over the last 1 years (from 61.275 to 64.500), reflecting consistent citation performance.
Impact Factors by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.500 | Journal Citation Reports (Clarivate) |
| 2023 | 61.275 | Journal Citation Reports (Clarivate) |
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
Sugen kinase 495 promotes the proliferation, migration and invasion of lung squamous cell carcinoma cells by targeting Foxo1 transcription factor
Yuanmei Lou, Jun Chen, Yangpeng Tang • 2026
Metadata
Last updated: Mar 20, 2026
Updated by: system